CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A
…philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with pharmaceutical and biotechnology companies…
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
…their work. The CMTA has invested $23.5 million in its Strategy to Accelerate Research (STAR) since it was implemented in 2008, making it the world’s largest funder of CMT research….
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
MDA and CMTA Partner to Advance Treatments and Care for Charcot-Marie-Tooth Disease
…the field and increasing collaboration among research and clinical investigators. With the launch of this partnership, MDA and CMTA plan to co-fund research and training grants, collaborate on infrastructure initiatives,…
STAR Advisory Board
…soundness of the research strategy. The progress of research teams, recommending changes in research strategies as needed. The Therapy Expert Board (TEB) evaluates the translational quality of ongoing and proposed…
CMTA Appoints David Skarinsky to its Therapy Expert Board
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research that’s aimed at bringing treatments and a cure to patients of this rare disease, is pleased to…
CMTA 2024 Year in Review Magazine
…to our community’s dedication, CMTA raised over $4.2 million to drive research and support programs that improve lives today while creating hope for tomorrow. Together, we are accelerating research and…
Development of Treatments for CMT2D
…support the CMTA’s research efforts and enable expanded partnerships with world leading research laboratories, please consider making a donation in support of the CMTA’s Strategy to Accelerate Research. Published: June…
CMTA Announces New Center of Excellence in Canada
…care and research, becoming a permanent staff member in 2019. His clinical and translational research centers on congenital myopathies and spinal muscular atrophy (SMA). Dr. Gonorazky co-leads a national effort…